India, March 17 -- Persistent Systems has announced a collaboration with NVIDIA to accelerate AI-powered solutions for the healthcare and life sciences (HLS) sector, including the launch of its Generative Molecules and Virtual Screening (GenMolVS) solution.
The partnership aims to enhance computational drug discovery by leveraging generative AI and advanced analytics, enabling faster and more efficient research outcomes.
Persistent will utilize the NVIDIA AI Enterprise platform for specialized life sciences applications, including preclinical research, allowing high-fidelity molecular simulations and large-scale virtual screening. This approach helps model biological and chemical behavior digitally before real-world lab testing.
The GenM...